本研究为一项前瞻性队列研究，旨在描述在无抗生素预防下进行经会阴前列腺穿刺活检后的感染结果及发生率，并与现有接受抗生素预防下经会阴前列腺穿刺活检患者的结果数据进行比较。
适应症：Prostate Cancer
入组条件
纳入标准
- All consecutive patients in participating centres receiving transperineal USG-guided biopsy for any indication including:
- Elevated PSA
- Abnormal DRE
- Follow-up biopsy in active surveillance
- Suspicion of CAP recurrence after radiotherapy
- Follow-up biopsy after focal therapy
- Consenting to the study
排除标准
- Recent suspected UTI within 1 month
- Recent culture proven bacteriuria within 1 month
- History of recurrent UTI
- Indwelling urinary catheter
- Immunocompromised state
- High risk of infective endocarditis (including prosthetic heart valve, congenital heart disease, or previous history of infective endocarditis
- Incompetent or incapable of understanding the nature of the study or giving informed consent
入组条件维持 ClinicalTrials.gov 原始英文登记资料，实际入组资格以研究团队的正式评估与受试者知情同意书为准。资料来源：ClinicalTrials.gov，每两周自动更新，最后同步：2026年10月8日。